ERBB2 c.1367G>T ;(p.R456L)

Variant ID: 17-37872046-G-T

NM_004448.2(ERBB2):c.1367G>T;(p.R456L)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Advanced Lung Adenocarcinoma Patient with ERBB2 Amplification Identified by Comprehensive Genomic Profiling Benefits from Trastuzumab.

Case Reports In Oncological Medicine
Tao, Chi-Wei CW; Chen, Mei-Yin MY; Tseng, Ching-Min CM; Lapke, Nina N; Chen, Shu-Jen SJ; Tan, Kien Thiam KT
Publication Date: 2020

Variant appearance in text: ERBB2: R456L
PubMed Link: 32190395
Variant Present in the following documents:
  • Main text
View BVdb publication page



Pan-cancer whole-genome analyses of metastatic solid tumours.

Nature
Priestley, Peter P; Baber, Jonathan J; Lolkema, Martijn P MP; Steeghs, Neeltje N; de Bruijn, Ewart E; Shale, Charles C; Duyvesteyn, Korneel K; Haidari, Susan S; van Hoeck, Arne A; Onstenk, Wendy W; Roepman, Paul P; Voda, Mircea M; Bloemendal, Haiko J HJ; Tjan-Heijnen, Vivianne C G VCG; van Herpen, Carla M L CML; Labots, Mariette M; Witteveen, Petronella O PO; Smit, Egbert F EF; Sleijfer, Stefan S; Voest, Emile E EE; Cuppen, Edwin E
Publication Date: 2019-11

Variant appearance in text: ERBB2: Arg456Leu
PubMed Link: 31645765
Variant Present in the following documents:
  • 41586_2019_1689_MOESM10_ESM.xlsx, sheet 1
View BVdb publication page